Cargando…
Overview of diagnostic/targeted treatment combinations in personalized medicine for breast cancer patients
Breast cancer includes a body of molecularly distinct subgroups, characterized by different presentation, prognosis, and sensitivity to treatments. Significant advances in our understanding of the complex architecture of this pathology have been achieved in the last few decades, thanks to new biotec...
Autores principales: | Tessari, Anna, Palmieri, Dario, Di Cosimo, Serena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883531/ https://www.ncbi.nlm.nih.gov/pubmed/24403841 http://dx.doi.org/10.2147/PGPM.S53304 |
Ejemplares similares
-
Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy
por: Di Cosimo, Serena
Publicado: (2009) -
Scorpins in the DNA Damage Response
por: Palmieri, Dario, et al.
Publicado: (2018) -
Cancer-Derived Extracellular Vesicle-Associated MicroRNAs in Intercellular Communication: One Cell’s Trash Is Another Cell’s Treasure
por: Mills, Joseph, et al.
Publicado: (2019) -
Precision medicine and personalized breast cancer: combination pertuzumab therapy
por: Reynolds, Kerry, et al.
Publicado: (2014) -
RANBP9 as potential therapeutic target in non-small cell lung cancer
por: Tessari, Anna, et al.
Publicado: (2020)